Percutaneous closure of atrial septal defects with the memopart atrial septal occluder: The early-term results of a multicenter study

dc.authorid0000-0002-3105-5472
dc.contributor.authorBaykan, Ali
dc.contributor.authorBilici, Meki
dc.contributor.authorNarin, Nazmi
dc.contributor.authorErdem, Abdullah
dc.contributor.authorÜzüm, Kazım
dc.contributor.authorAkın, Alper
dc.contributor.authorPamukçu, Özge
dc.contributor.authorBalık, Hasan
dc.contributor.authorTüre, Mehmet
dc.contributor.authorVural, Çağdaş
dc.contributor.authorDoğan, Alper
dc.date.accessioned2023-01-05T10:53:41Z
dc.date.available2023-01-05T10:53:41Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractAtrial septal defect (ASD) is a common congenital heart disease with left-to-right shunt that may lead to pulmonary hypertension over time. Secundum ASD closure with transcatheter technique is currently the preferred method. The aim of this study was to evaluate the clinical experience and early-term outcomes of patients treated with a MemoPart ASD occluder device between June 2013 and June 2019. Fifty-six patients (35 females) with a mean age of 9.4 +/- 6.6 years (range: 2-44 years) were included in the study. The diameters of the devices used to close the ASDs were 7-28 mm. The ratio of the device/defect diameter was 1.14:1. Atrial septal defect closure was applied successfully in all patients. The MemoPart septal occluder is a safe and effective device for ASD closure. In wide ASDs and cases with more than one deficient rim, weak rims, or wide and complicated cases, it can be used carefully with sufficient experience.
dc.description.sponsorshipErciyes Universityen_US
dc.identifier.citationBaykan, A., Bilici, M., Narin, N., Erdem, A., Üzüm, K., Akın, A. ... Doğan, A. (2022). Percutaneous closure of atrial septal defects with the memopart atrial septal occluder: The early-term results of a multicenter study. Pediatric Cardiology, 43(1), 39-44. https://dx.doi.org/10.1007/s00246-021-02688-w
dc.identifier.doi10.1007/s00246-021-02688-w
dc.identifier.endpage44
dc.identifier.issn0172-0643
dc.identifier.issn1432-1971
dc.identifier.issue1
dc.identifier.pmid34401943
dc.identifier.scopus2-s2.0-85112528076
dc.identifier.scopusqualityQ2
dc.identifier.startpage39
dc.identifier.urihttps://dx.doi.org/10.1007/s00246-021-02688-w
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10247
dc.identifier.volume43
dc.identifier.wos000685367000001en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorErdem, Abdullah
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofPediatric Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAtrial Septal Defect
dc.subjectChildren
dc.subjectMemoPart
dc.subjectTranscatheter
dc.titlePercutaneous closure of atrial septal defects with the memopart atrial septal occluder: The early-term results of a multicenter study
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: